PATENT CLAIM ANALYSIS

Application Number: 15970486
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "089000"]

Abstract:
A crystalline form of crystalline (R)-3-(4-(2-(2-methyltetrazol-5-yl)-pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate, methods of making the crystalline form and pharmaceutical compositions comprising the crystalline form are useful antibiotics. Further, the derivatives of the present invention may exert potent antibacterial activity versus various human and animal pathogens, including Gram-positive bacteria such as Staphylococi, Enterococci and Streptococi, anaerobic microorganisms such as  Bacteroides  and Clostridia, and acid-resistant microorganisms such as  Mycobacterium tuberculosis  and  Mycobacterium avium.  Accordingly, the compositions comprising the crystalline form may be used in antibiotics.

Claim (Index 2):
The compound of  claim 1  having an x-ray powder diffraction pattern comprising the following peaks: 14.7\u00b0, 15.2\u00b0, 16.6\u00b0, 20.3\u00b0, 26.8\u00b0, and 28.2\u00b0.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 93.0
- Lexical Diversity: 1.68254
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14959412', '15455463', '15970492', '12699864', '12211655']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7864027828487252
- 35 USC 102 Novelty (BERT): 0.5304110852377397
- Combined Prediction Score: 0.7608036130876267
- Mean Citation Score: 319.5580980000001
- Max Citation Score: 361.5786
- Similarity Product: 253.1701235687256

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test